XOOMAR

INVO Fertility (IVF)

INVO Fertility on one page: short interest, daily short volume, fails to deliver, large holders, earnings dates and insider trades. Listed on Nasdaq.

Download CSV

26K

Short interest

settlement 2026-10-15

1.0

Days to cover

unchanged vs prior

11.0%

Short share of volume

2026-11-02

2,483

Fails to deliver

settlement 2026-10-09

Mon 16 Nov

Next earnings

estimated date

$0

Insider flow, 90 days

0 buys, 0 sells

As of 2026-11-02.

Short interest

FINRA, twice a month. The newest 36 settlements in the table, 36 in the chart. JSON

As of 15 October 2026, short interest in IVF is 26,478 shares, down 167,217 shares over the last month. Over the last 36 readings it ranged from 11,952 shares (30 September 2025) to 760,242 shares (30 June 2026). The latest reading sits at the bottom of that range. At the reported average volume of 140K shares a day that is 1.0 days to cover.

Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/ivf" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
PreviewDark previewAdd ?theme=dark to the src for a dark chart.
SettlementShares shortChangeAvg daily volumeDays to cover
2026-10-1526,478-47.2%140,4701.00
2026-09-3050,118-74.1%151,1041.00
2026-09-15193,695-47.3%138,9171.39
2026-08-31367,548+60.9%11,714,8281.00
2026-08-14228,460-5.1%55,9484.08
2026-07-31240,800-7.4%104,1142.31
2026-07-15260,114-65.8%358,6781.00
2026-06-30760,242+461.7%12,658,9391.00
2026-06-15135,347+46.8%268,1311.00
2026-05-2992,196-25.1%1,442,2531.00
2026-05-15123,076+17.2%46,6922.64
2026-04-30105,026+9.8%32,2923.25
2026-04-1595,664+21.1%45,3912.11
2026-03-3179,020-76.3%78,4961.01
2026-03-13333,878-37.4%257,5771.30
2026-02-27533,091+87.3%1,337,8491.00
2026-02-13284,595-19.7%425,8211.00
2026-01-30354,428+762.2%40,305,2471.00
2026-01-1541,109-37.8%178,9911.00
2025-12-3166,048-30.1%127,0521.00
2025-12-1594,554+281.1%982,1551.00
2025-11-2824,811-90.0%1,068,7791.00
2025-11-14249,428+6.3%1,042,6821.00
2025-10-31234,717+523.6%23,784,6571.00
2025-10-1537,641+214.9%159,3371.00
2025-09-3011,952-63.2%131,4231.00
2025-09-1532,512-0.7%339,6901.00
2025-08-2932,737-57.7%481,4371.00
2025-08-1577,354-63.3%1,342,1911.00
2025-07-31210,638+121.5%5,971,2101.00
2025-07-1595,082-36.9%141,2641.00
2025-06-30150,584+979.3%1,026,9841.00
2025-06-1313,952-55.4%112,6531.00
2025-05-3031,271+14.9%248,0881.00
2025-05-1527,219-73.8%4,326,4721.00
2025-04-30103,762+219.8%8,626,4141.00

Daily short volume

FINRA Reg SHO, the last 30 sessions. JSON

As of 2 November 2026, the short share of IVF volume is 11.0%, down 18.5 points over the last five sessions. Over the last 30 readings it ranged from 11.0% (2 November 2026) to 79.5% (27 October 2026). The latest reading sits at the bottom of that range. The latest reading is 24.0 points below the 30-session average of 35.0%, on 30K shares reported.

DateShort volumeTotal volumeShort shareExempt
2026-11-023K30K11.0%553
2026-10-3031K81K38.6%4,530
2026-10-2925K72K34.8%0
2026-10-2831K126K24.6%0
2026-10-2720K25K79.5%0
2026-10-264K14K29.6%0
2026-10-2310K28K33.9%0
2026-10-222K13K15.6%1,011
2026-10-2115K55K28.3%0
2026-10-2012K40K30.4%0
2026-10-199K64K14.0%924
2026-10-1627K60K45.5%18,133
2026-10-1518K93K19.8%2,605
2026-10-1414K73K18.7%5,391
2026-10-1386K154K55.5%4,807
2026-10-1224K57K41.7%0
2026-10-0913K61K21.2%0
2026-10-086K37K16.6%5,102
2026-10-0728K71K39.6%0
2026-10-069K36K23.9%1,447
2026-10-0525K80K31.7%423
2026-10-0257K126K45.3%103
2026-10-0142K71K58.8%0
2026-09-3015K46K32.9%0
2026-09-2918K46K39.7%0
2026-09-2811K44K26.2%0
2026-09-25189K357K53.1%3,660
2026-09-2413K53K24.6%1,500
2026-09-2362K92K67.3%0
2026-09-2232K67K48.0%0

Fails to deliver

SEC, the last 30 settlement dates with a fail. JSON

As of 9 October 2026, the fails-to-deliver balance in IVF is 2,483 shares, down 4,876 shares over the last settlement date. Over the last 30 readings it ranged from 2 shares (21 August 2026) to 278,539 shares (18 August 2026). The latest reading sits at the bottom of that range.

SettlementShares failedPriceValue
2026-10-092,483$0.74$2K
2026-10-087,359$0.74$5K
2026-10-06139$0.83$115
2026-10-0217$0.90$15
2026-09-283,649$0.94$3K
2026-09-243,006$1.02$3K
2026-09-233,019$1.00$3K
2026-09-163,670$0.95$3K
2026-09-152,063$0.95$2K
2026-09-141,970$0.97$2K
2026-09-10758$0.96$728
2026-09-098,068$0.98$8K
2026-09-03866$1.01$875
2026-08-262,200$1.06$2K
2026-08-2521,069$1.03$22K
2026-08-212$1.15$2
2026-08-2030,088$1.13$34K
2026-08-19194,111$1.43$278K
2026-08-18278,539$1.53$426K
2026-08-1712,846$0.97$12K
2026-08-149,622$0.97$9K
2026-08-1314,125$1.01$14K
2026-08-121,541$1.03$2K
2026-08-113,380$1.04$4K
2026-08-106,466$1.06$7K
2026-08-0611,849$1.08$13K
2026-08-0516,070$1.05$17K
2026-08-0415,730$0.98$15K
2026-08-0321,964$0.94$21K
2026-07-3128,352$0.94$27K

Insider trades

SEC Form 4, newest first. JSON

No open-market insider trades were reported for IVF in the last 90 days. The most recent filings are listed below. Latest filing: Szot Matthew K (Director) on 2025-12-04.

DateInsiderTitleTypeSharesPriceValueOwned after
2025-12-04Szot Matthew KDirectorOther transaction3$0.00$00
2025-12-03Szot Matthew KDirectorSell4$1.52$63

Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.

Large holders (13D and 13G)

One row per reporting person with its latest filing, newest first. JSON

5 holders report 5% or more of IVF in their latest filing, all on Schedule 13G (passive). The largest reported stake is Alumni Capital LP at 10.0% of the class (272,249 shares), filed 2026-08-07 for an event on 2026-08-04.

FiledFormHolderSharesOf classEvent
2026-10-0913G/Ano. 1Glenbrook Capital Managementcorporation35K1.4%2026-06-30
2026-08-1413G/Ano. 2Armistice Capital, LLCinvestment adviser, other entity121K5.0%2026-06-30
2026-08-1413G/Ano. 2Steven Boydparent holding company, individual121K5.0%2026-06-30
2026-08-0713GAlumni Capital LPpartnership272K10.0%2026-08-04
2026-08-0713GAlumni Capital GP LLCother entity272K10.0%2026-08-04
2026-08-0713GAshkan Maparindividual272K10.0%2026-08-04
2026-01-2113G/Ano. 1Five Narrow Lane LPother entity7K0.3%2026-01-20
2025-10-2813GGreenblock Capital, LLCother entity618K10.0%2025-06-25
2025-10-2813GSPENCER CHRISTOPHER Jindividual618K10.0%2025-06-25

What this page is

INVO Fertility in the regulatory record

Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.

Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.

This page follows INVO Fertility (IVF), SEC CIK 1417926, listed on Nasdaq. The cross-market tables live on the short interest and insider transactions hubs.

Source and updates

Short interest
FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-10-15.JSON and CSV
Daily short volume
FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-11-02.JSON and CSV
Fails to deliver
SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-10-09.JSON and CSV
Large holders
SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-10-09.JSON and CSV
Earnings dates
SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-08-17.JSON and CSV
Insider trades
SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2025-12-04.JSON and CSV
Company record
EDGAR filing index for CIK 1417926Ticker, name and exchange from the SEC's company list, refreshed weekly.
Rate limits
10 requests a minute without a key, 30 with a free key from a free account.

How to read it

  • Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
  • Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
  • Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.

Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.

Datasets

Frequently Asked Questions

How much of IVF is sold short?
26,478 shares were held short at the 2026-10-15 settlement, 1.0 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.
What is IVF's daily short volume?
On 2026-11-02, 3,267 of the 29,599 IVF shares reported to FINRA were sold short, 11.0% of the day's reported volume. Short volume is a flow for one day, not a position.
Does IVF have fails to deliver?
The SEC's latest file shows 2,483 IVF shares failed to deliver at settlement 2026-10-09. Fails are reported per settlement date and published twice a month with a lag.
Are IVF insiders buying or selling?
No open-market insider trades were reported for IVF in the last 90 days. The most recent filings are listed below. Latest filing: Szot Matthew K (Director) on 2025-12-04.
Who owns 5% or more of IVF?
5 holders report 5% or more of IVF in their latest filing, all on Schedule 13G (passive). The largest reported stake is Alumni Capital LP at 10.0% of the class (272,249 shares), filed 2026-08-07 for an event on 2026-08-04.

Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.